CyBio AG: Sales increased
CyBio AG finished the year 2004 with 12.5 Mio. EUR in sales (plus 3.3 percent over previous year). Loss from operation has been reduced significantly in the second half of the year. Cash flow and operational results (EBIT) for the fourth quarter were positive. Compared to prior years loss from operation, 2004 result will be significantly better. With its operating business CyBio increased its cash by 1 Mio. EUR . Liquid funds of the Group at year end amounted to 4.3 Mio. EUR (prior year 3.3 Mio. EUR ).
Last week CyBio signed a long term agreement with CLONDIAG chip technologies GmbH for delivery of an automatic pipetting and analyzing instrument for the laboratory diagnostics industry. CyBio AG will publish the audited financial statement of 2004 on 30th March, 2005.
Most read news
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.